CD56-positive diffuse large B-cell lymphoma: comprehensive analysis of clinical, pathological, and molecular characteristics with literature review Cover

.blurhash-client-img { display: none !important; }

CD56-positive diffuse large B-cell lymphoma: comprehensive analysis of clinical, pathological, and molecular characteristics with literature review

Radiology and Oncology

Volume 57 (2023): Issue 2 (June 2023)

By: Gorana Gasljevic, Lucka Boltezar, Srdjan Novakovic, Vita Setrajcic-Dragos, Barbara Jezersek-Novakovic and Veronika Kloboves-Prevodnik

Open Access

|Mar 2023

Authors

Gorana Gasljevic

Institute of Oncology Ljubljana, Ljubljana, Slovenia

Lucka Boltezar

Institute of Oncology Ljubljana, Ljubljana, Slovenia

Srdjan Novakovic

Institute of Oncology Ljubljana, Ljubljana, Slovenia

Vita Setrajcic-Dragos

Institute of Oncology Ljubljana, Ljubljana, Slovenia

Barbara Jezersek-Novakovic

Institute of Oncology Ljubljana, Ljubljana, Slovenia

Veronika Kloboves-Prevodnik

vkloboves@onko-i.si

Institute of Oncology Ljubljana, Ljubljana, Slovenia

DOI: https://doi.org/10.2478/raon-2023-0016 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099

Journal RSS Feed

Language: English

Page range: 249 - 256

Submitted on: Jan 9, 2023

|

Accepted on: Feb 19, 2023

|

Published on: Mar 21, 2023

Published by: Association of Radiology and Oncology

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

diffuse large B-cell lymphoma not otherwise specified,

immunohistochemistry,

genetic profiling,

Related subjects:

Clinical medicine,

Internal medicine,

Haematology, oncology,

© 2023 Gorana Gasljevic, Lucka Boltezar, Srdjan Novakovic, Vita Setrajcic-Dragos, Barbara Jezersek-Novakovic, Veronika Kloboves-Prevodnik, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.

Previous article Volume 57 (2023): Issue 2 (June 2023)Next article